Dr. Richard Heyman advises Peptone on drug discovery and company building. A scientist and biotechnology entrepreneur, he co-founded and led Aragon and Seragon Pharmaceuticals and now chairs Architect Therapeutics, a small molecule discovery company. He has been involved in developing multiple FDA approved therapies, including Erleada for prostate cancer, and has chaired biotechnology companies including Vividion Therapeutics, Amunix Pharma, and RayzeBio.
Scientific Advisor for Drug Discovery and Company Building